The study found that high doses of Vioxx known as rofecoxib tripled risks of heart attacks and sudden cardiac death.
Merck took the drastic step of pulling Vioxx because its research showed it caused increased risk of heart attack.
Merck & Co. removed Vioxx from use after new study results showed increased risk of heart attacks and stroke in people who used it for longer than 18 months.
Merck officials said its latest research showed an increased risk of heart attack and other cardiovascular complications in patients who took Vioxx for at least 18 months.

